WANG F , QIN S , SUN X , et al . Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial [J]. J Hematol Oncol , 2020 , 13 ( 1 ): 47 .
WU J , SONG Y , CHEN X , et al . Camrelizumab for relapsed or refractory classical hodgkin lymphoma: extended follow-up of the multicenter, single-arm, phase 2 study [J]. Int J Cancer . 2022 , 150 ( 6 ): 984 - 992 .
LUO H , LU J , BAI Y , et al . Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma: the ESCORT-1st randomized clinical trial [J]. JAMA , 2021 , 326 ( 10 ): 916 - 925 .
LAN C , SHEN J , WANG Y , et al . Camrelizumab plus apatinib in patients with advanced cervical cancer (CLAP): a multicenter, open-label, single-arm, phase Ⅱ trial [J]. J Clin Oncol , 2020 , 38 ( 34 ): 4095 - 4106 .
ZHOU H , WANG Y , LIN Y , et al . Preliminary efficacy and safety of camrelizumab in combination with XELOX plus bevacizumab or regorafenib in patients with metastatic colorectal cancer: a retrospective study [J]. Front Oncol , 2021 , 11 : 774445 . doi: 10.3389/fonc.2021.774445 http://dx.doi.org/10.3389/fonc.2021.774445 .
SONG H , LIU X , JIANG L , et al . Current status and prospects of camrelizumab, a humanized antibody against programmed cell death receptor 1 [J]. Recent Pat Anticancer Drug Discov , 2021 , 16 ( 3 ): 312 - 332 .
Exploring the Comorbidity Mechanism,Prevention and Treatment Strategies of Rheumatoid Arthritis with Coronary Atherosclerotic Heart Disease Based on Collateral Disease Theory
Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"
Effect of Xiaoqinglong Decoction (小青龙汤) on Th2 Immune Responses and Nasal Mucosal TSLP/OX40L Pathway in Allergic Rhinitis Model Rats
Research on the Correlation Between "Tiangui (天癸)" and Female Reproductive Genetic Diseases
Construction and Application of "Source-Pivot-Convergence" Pattern Identification and Treatment Model for Malignant Tumors